A breast cancer gene signature for indolent disease

PURPOSE: Early-stage hormone-receptor positive breast cancer is treated with endocrine therapy and the recommended duration of these treatments has increased over time. While endocrine therapy is considered less of a burden to patients compared to chemotherapy, long-term adherence may be low due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Delahaye, Leonie J. M. J., Drukker, Caroline A., Dreezen, Christa, Witteveen, Anke, Chan, Bob, Snel, Mireille, Beumer, Inès J., Bernards, Rene, Audeh, M. William, van’t Veer, Laura J., Glas, Annuska M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487706/
https://www.ncbi.nlm.nih.gov/pubmed/28451965
http://dx.doi.org/10.1007/s10549-017-4262-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487706/
https://www.ncbi.nlm.nih.gov/pubmed/28451965
http://dx.doi.org/10.1007/s10549-017-4262-0

Ejemplares similares